GCGR and dysplasia: In GCGR -/- mice, the progression from pancreatic endocrine cell mass expansion with ACH to dysplasia at 5 to 7 months, proceeding to pNETs < 1 mm at 12 months and then to pNETs > 1 mm at 18 months is well-established (13, 14).